Drug Research
Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
Evotec SE announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic diseases with a focus on kidney diseases and diabetes.
The collaboration leverages Evotec’s extensive experience and...
Drug Research
Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell -based disease modelling for ophthalmologic disorders. Millions of people are affected by vision-related diseases worldwide, and there...
Drug Research
Lonza, Forbion, and BioGeneration Ventures Extend Collaboration to Add Development and Manufacturing Services of Small Molecules
Forbion, a leading venture capital firm building life sciences companies, BioGeneration Ventures (BGV), its joint venture partner and specialized life sciences venture capital firm focusing on early-stage European biotech companies, together with Lonza, a global development and manufacturing partner...
Drug Research
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
Abbisko Therapeutics Co., Ltd., a subsidiary of Abbisko Cayman Limited announced that it has entered into a worldwide collaboration and exclusive licensing agreement with Eli Lilly and Company for the further discovery, development and potential commercialization of novel molecules...
Drug Research
Neurimmune expands drug discovery collaboration with Ono Pharmaceutical in the field of neurodegenerative diseases
Neurimmune AG announced that it has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. The collaboration is focused on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases utilizing Neurimmune’s proprietary...
Drug Research
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, announced a strategic collaboration and option agreement for the use of Mammoth’s CRISPR systems to develop in vivo gene-editing therapies.
Mammoth...
Drug Research
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples. The companies have been working together...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read